Literature DB >> 20079717

Oxidative stress and defective platelet apoptosis in naïve patients with Kawasaki disease.

Elisabetta Straface1, Lucrezia Gambardella, Alessio Metere, Alessandra Marchesi, Giuseppe Palumbo, Elisabetta Cortis, Alberto Villani, Donatella Pietraforte, Marina Viora, Walter Malorni, Domenico Del Principe.   

Abstract

Kawasaki disease (KD) is a rare and often undiagnosed disease, at least in the western countries. It is characterized by an inflammatory acute febrile vasculitis of medium sized arteries with a propensity to damage the coronary arteries. It normally occurs in the early childhood and the diagnosis is based on clinical symptoms. During the progression of the disease thrombocytosis is usually detected. This can exert a pathogenetic role in the cardiovascular complications occurring in KD. In the present work peripheral blood plasma and platelets from twelve naïve patients with KD were analyzed in order to detect possible pathogenetic determinants or progression markers. Morphological, biochemical and flow cytometrical methods have been used. With respect to age-matched healthy donors, we found an increase of platelet activation markers, i.e. degranulation, phosphatidylserine (PS) externalization and leukocyte-red cell-platelet aggregates. Some significant alterations that could represent suitable diagnostic determinants have also been detected in patient plasma: (i) decreased antioxidant power, (ii) decreased levels of asymmetric dymethylarginine (ADMA), a naturally occurring chemical interfering with the production of nitric oxide, and (iii) increased levels of soluble P-Selectin and soluble annexin V. Since PS externalizing platelets are known to exert a pro-coagulant activity, our data suggest the hypothesis that increased risk of vascular complications in KD could depend on platelet stimulation and defective apoptosis probably related to nitrosative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079717     DOI: 10.1016/j.bbrc.2010.01.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Regulation of oxidative stress in patients with Kawasaki disease.

Authors:  Kaori Sekine; Hiroyuki Mochizuki; Yoshinari Inoue; Tohru Kobayashi; Eisuke Suganuma; Shinichi Matsuda; Hirokazu Arakawa
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.

Authors:  Feifei Si; Yao Wu; Fang Gao; Siqi Feng; Ruixi Liu; Qijian Yi
Journal:  Clin Exp Med       Date:  2017-01-20       Impact factor: 3.984

3.  Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura.

Authors:  Nurcan Keskin; Mahmut Civilibal; Murat Elevli; Macit Koldas; Nilgun Selcuk Duru; Humeyra Ozturk
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

4.  In Vitro Susceptibility of Wistar Rat Platelets to Hydrogen Peroxide and AAPH-Induced Oxidative Stress.

Authors:  K Manasa; R Vani
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-11       Impact factor: 0.900

Review 5.  Pathogenetic determinants in Kawasaki disease: the haematological point of view.

Authors:  Domenico Del Principe; Donatella Pietraforte; Lucrezia Gambardella; Alessandra Marchesi; Isabella Tarissi de Jacobis; Alberto Villani; Walter Malorni; Elisabetta Straface
Journal:  J Cell Mol Med       Date:  2017-01-07       Impact factor: 5.310

Review 6.  Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

Authors:  Alessandra Marchesi; Isabella Tarissi de Jacobis; Donato Rigante; Alessandro Rimini; Walter Malorni; Giovanni Corsello; Grazia Bossi; Sabrina Buonuomo; Fabio Cardinale; Elisabetta Cortis; Fabrizio De Benedetti; Andrea De Zorzi; Marzia Duse; Domenico Del Principe; Rosa Maria Dellepiane; Livio D'Isanto; Maya El Hachem; Susanna Esposito; Fernanda Falcini; Ugo Giordano; Maria Cristina Maggio; Savina Mannarino; Gianluigi Marseglia; Silvana Martino; Giulia Marucci; Rossella Massaro; Christian Pescosolido; Donatella Pietraforte; Maria Cristina Pietrogrande; Patrizia Salice; Aurelio Secinaro; Elisabetta Straface; Alberto Villani
Journal:  Ital J Pediatr       Date:  2018-08-30       Impact factor: 2.638

7.  Potential role of platelets for atherosclerotic events in rheumatoid arthritis.

Authors:  Rosa Vona; Manuela Di Franco; Lucrezia Gambardella; Anna C Di Lollo; Cristina Iannuccelli; Guido Valesini; Walter Malorni; Elisabetta Straface
Journal:  FEBS Open Bio       Date:  2018-11-06       Impact factor: 2.693

8.  Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment.

Authors:  Li-Yan Lin; Tsung-Hsien Yang; Ying-Jui Lin; Hong-Ren Yu; Kuender D Yang; Yi-Chuan Huang; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  Pediatr Cardiol       Date:  2012-03-25       Impact factor: 1.655

9.  The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease.

Authors:  Jing Zhang; Haobo Weng; Qiongfei Pei; Penghui Yang; Wentao Fan; Ruixi Liu; Qijian Yi
Journal:  Clin Exp Med       Date:  2021-07-07       Impact factor: 3.984

10.  Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease.

Authors:  Lauren L Ching; Vivek R Nerurkar; Eunjung Lim; Ralph V Shohet; Marian E Melish; Andras Bratincsak
Journal:  Front Pediatr       Date:  2020-06-25       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.